Five steps to take when the duty for developing Risk Evaluation and Mitigation Strategies (REMS) is imposed on commercial operations
Regina Murphy, McKesson Specialty Care Solutions
Advertisement
Articles by Regina Murphy, McKesson Specialty Care Solutions
Advertisement
Latest Updated Articles
- Dealing With REMS Challenges in Drug Commercialization
Published: August 19th 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
What MFN Pricing Means for Future Drug Development
3
Strive Pharmacy Breaks Ground on Arizona HQ
4
Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics
5
